Le Lézard
Classified in: Health, Science and technology
Subject: Conference

Schrödinger to Participate in Upcoming Investor Conferences


Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in the following conferences in March:

The live discussions can be accessed in the "Investors" section of Schrödinger's website and will be archived for approximately 90 days.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger's multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.

Founded in 1990, Schrödinger has approximately 850 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.


These press releases may also interest you

at 11:50
Addentax Group Corp. ("Addentax" or the "Company") , an integrated service provider focusing on garment manufacturing, logistics services, property management, and subleasing, has announced that it has entered into Private Placement Agreements (the...

at 11:47
Digital Moment, in partnership with the Raspberry Pi Foundation and Google DeepMind, is proud to announce the launch of Experience AI, an educational program designed to support teachers in the fascinating but rapidly evolving field of artificial...

at 11:46
Single Pass, Inc. is proud to announce that its Class II Kronos biopsy closure device has received clearance from the U.S. Food and Drug Administration (FDA). The FDA has determined the device is substantially equivalent to predicate devices...

at 11:45
Euro Sun Mining Inc., ("Euro Sun" or the "Company") is pleased to announce that it has issued a convertible promissory note (the "Note") to John Robins and James Paterson (the "Lenders") providing for a principal amount of US$200,000 (the "Principal...

at 11:36
SXNY Holdings LLC, is excited to announce the acquisition of Saxony Partners, founded in 2011 by Jeff Wilson as a real estate technology company, expanding to include a Yardi practice in 2017. In recent years, Saxony has dedicated its efforts...

at 11:35
Snowflake , the Data Cloud company, today announced it will release its financial results for the first quarter of fiscal year 2025, which ends April 30, 2024, following the close of the U.S. markets on Wednesday, May 22, 2024. Snowflake will host a...



News published on and distributed by: